Richard M. Weinshilboum

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression

Xianlin Han, A. Rush, M. Frye, 2020, bioRxiv.

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects

M. Frye, R. Weinshilboum, J. Biernacka, 2015, Translational Psychiatry.

Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis.

A. Ozerdem, S. Winham, N. Nuñez, 2023, Journal of women's health.

IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study

M. Skime, Hu Li, Ming-Fen Ho, 2024, Brain, Behavior, and Immunity.

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

M. Rietschel, K. Tansey, G. Breen, 2017, bioRxiv.